Martinho Tojo
Director/Board Member presso Bynd Venture Capital
Profilo
Martinho Tojo is currently the Managing Director at Bynd Venture Capital, a Director at Lymphact - Lymphocyte Activation Technologies SA, a Board Member at Faber Ventures SA, and a Board Member at PNV Capital SA. Previously, he was the Senior Vice President-Portugal at Cogeco Communications, Inc. and the Senior Vice President & General Manager at NOWO Communications SA from 2009 to 2010.
Posizioni attive di Martinho Tojo
| Società | Posizione | Inizio |
|---|---|---|
Bynd Venture Capital
 Bynd Venture Capital Investment ManagersFinance Bynd Venture Capital (Bynd) is a venture capital located and headquartered in Lisbon, Portugal. It was co-founded by Santiago Salazar in 2010 under the name Busy Angels SCR SA and changed to its current name in 2019. | Director/Board Member | 02/05/2013 |
PNV Capital SA
 PNV Capital SA Investment ManagersFinance PNV Capital SA is an independent venture capital firm headquartered in Portugal. The firm was founded in 2010 by Luís Paulo Tenente. | Director/Board Member | 23/07/2013 |
Faber Ventures SA
 Faber Ventures SA Investment ManagersFinance Faber Ventures SA (Faber Ventures) is an independent venture capital firm founded in 2012 by Pedro do Carmo Costa and Rui Correia Nunes. The firm is headquartered in Lisbon, Portugal. | Director/Board Member | 27/12/2013 |
Lymphact - Lymphocyte Activation Technologies SA
 Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Director/Board Member | - |
Precedenti posizioni note di Martinho Tojo
| Società | Posizione | Fine |
|---|---|---|
| COGECO COMMUNICATIONS INC. | Corporate Officer/Principal | - |
NOWO Communications SA
 NOWO Communications SA Cable/Satellite TVConsumer Services Nowo Communications SA provides telecommunication services. It offers cable network, Internet connection, television access, and voice services. The company was founded in 1993 and is headquartered in Palmela, Portugal. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| COGECO COMMUNICATIONS INC. | Consumer Services |
| Aziende private | 5 |
|---|---|
NOWO Communications SA
NOWO Communications SA Cable/Satellite TVConsumer Services Nowo Communications SA provides telecommunication services. It offers cable network, Internet connection, television access, and voice services. The company was founded in 1993 and is headquartered in Palmela, Portugal. | Consumer Services |
Faber Ventures SA
Faber Ventures SA Investment ManagersFinance Faber Ventures SA (Faber Ventures) is an independent venture capital firm founded in 2012 by Pedro do Carmo Costa and Rui Correia Nunes. The firm is headquartered in Lisbon, Portugal. | Finance |
PNV Capital SA
PNV Capital SA Investment ManagersFinance PNV Capital SA is an independent venture capital firm headquartered in Portugal. The firm was founded in 2010 by Luís Paulo Tenente. | Finance |
Bynd Venture Capital
Bynd Venture Capital Investment ManagersFinance Bynd Venture Capital (Bynd) is a venture capital located and headquartered in Lisbon, Portugal. It was co-founded by Santiago Salazar in 2010 under the name Busy Angels SCR SA and changed to its current name in 2019. | Finance |
Lymphact - Lymphocyte Activation Technologies SA
Lymphact - Lymphocyte Activation Technologies SA BiotechnologyHealth Technology Lymphact - Lymphocyte Activation Technologies SA provides biotechnology solutions. It develops treatments for cancer and chronic viral diseases. The firm offers a technology platform that generates autologous and heterologous cellular immune therapies for clinical applications. The company was founded by Diogo Remechido in 2013 and is headquartered in Lisbon, Portugal. | Health Technology |
- Borsa valori
- Insiders
- Martinho Tojo
